Literature DB >> 10858016

Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180.

M L Enss1, M Cornberg, S Wagner, A Gebert, M Henrichs, R Eisenblätter, W Beil, R Kownatzki, H J Hedrich.   

Abstract

OBJECTIVES AND
DESIGN: Proinflammatory cytokines and a defective mucus layer are involved in the pathogenesis of colitis. Therefore, we determined cytokine effects on MUC gene expression and mucin secretion.
MATERIALS AND METHODS: LS180 cells were characterized by light and electron microscopy and subsequently exposed to interleukin 1 (IL-1, 1 ng/ml), interleukin 6 (IL-6, 10 ng/ml), or tumor necrosis factor-alpha (TNFalpha, 10 ng/ml). MUC gene (MUC2, MUC5AC, MUC5B, MUC6) mRNA expression was assessed by RT-PCR, the encoded proteins were identified by immunocytochemistry and Western blotting, and the released mucins were isolated and chromatographically characterized.
RESULTS: Thirty to 40% of the cells contained intracellular mucin granules. Incubation with IL-1 transiently stimulated the mRNA expression of MUC2 and MUC5AC, whereas IL-6 induced an early response of MUC2, MUC5B and MUC6. TNFalpha upregulated the expression of MUC2 and MUC5B for 3 hours, and had no effect on the expression of MUC 5AC and MUC6. Immunocytochemistry and Western blotting confirmed TNFalpha effects on MUC2 and MUC5AC on the protein levels. All cytokines stimulated the release of less glycosylated mucins and considerably modulated their carbohydrate composition.
CONCLUSION: Our data demonstrate differential cytokine effects on mucin synthesis, secretion and composition. These alterations may contribute to the defective mucus layer in colitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858016     DOI: 10.1007/s000110050576

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  51 in total

1.  Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei.

Authors:  Haroon Asif Choudry; Arun Mavanur; Mark E O'Malley; Herbert J Zeh; Z Sheng Guo; David L Bartlett
Journal:  Ann Surg Oncol       Date:  2012-05       Impact factor: 5.344

2.  Host inflammatory response inhibits Escherichia coli O157:H7 adhesion to gut epithelium through augmentation of mucin expression.

Authors:  Yansong Xue; Hanying Zhang; Hui Wang; Jia Hu; Min Du; Mei-Jun Zhu
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

3.  Roles and regulation of the mucus barrier in the gut.

Authors:  Steve Cornick; Adelaide Tawiah; Kris Chadee
Journal:  Tissue Barriers       Date:  2015-04-03

Review 4.  Cathelicidins in inflammation and tissue repair: Potential therapeutic applications for gastrointestinal disorders.

Authors:  William Ka Kei Wu; Clover Ching Man Wong; Zhi Jie Li; Lin Zhang; Shun Xiang Ren; Chi Hin Cho
Journal:  Acta Pharmacol Sin       Date:  2010-08-02       Impact factor: 6.150

5.  Pasteurella multocida specific bacteriophage suppresses P. multocida-induced inflammation: identification of genes related to bacteriophage signaling by Pasteurella multocida-infected swine nasal turbinate cells.

Authors:  Ga Young Park; Hyun Jin Yu; Jee Soo Son; Sang Joon Park; Hee-Jae Cha; Kyoung Seob Song
Journal:  Genes Genomics       Date:  2019-12-18       Impact factor: 1.839

6.  MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptor pathway in the human gallbladder.

Authors:  Laetitia Finzi; Véronique Barbu; Pierre-Regis Burgel; Martine Mergey; Kimberly S Kirkwood; Elizabeth C Wick; Jean-Yves Scoazec; Frédérique Peschaud; François Paye; Jay A Nadel; Chantal Housset
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

7.  Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas.

Authors:  Mark Wahrenbrock; Lubor Borsig; Dzung Le; Nissi Varki; Ajit Varki
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 8.  Obesity-associated cancer risk: the role of intestinal microbiota in the etiology of the host proinflammatory state.

Authors:  Zora Djuric
Journal:  Transl Res       Date:  2016-07-28       Impact factor: 7.012

9.  Hypoxia-inducible factor 1 in dendritic cells is crucial for the activation of protective regulatory T cells in murine colitis.

Authors:  K Flück; G Breves; J Fandrey; S Winning
Journal:  Mucosal Immunol       Date:  2015-07-29       Impact factor: 7.313

10.  Mucin dynamics in intestinal bacterial infection.

Authors:  Sara K Lindén; Timothy H J Florin; Michael A McGuckin
Journal:  PLoS One       Date:  2008-12-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.